Two stocks in Consumer Defensive
Keurig Dr Pepper vs Kenvue: profit, growth, debt and price compared
Keurig Dr Pepper is stronger on 4 of 7 figures: sales growth, price for its expected profit, analysts' view and price trend. Kenvue is stronger on 3: profit margin, debt and dividend.
Save both stocks to your watchlist and revisit their latest fundamentals.
| Keurig Dr PepperKDP | KenvueKVUE | |
|---|---|---|
| Net margin | 7.1% | Stronger: 10.9% |
| Revenue growth, past year | Stronger: +70.55% | +3.24% |
| Debt to equity | 95.0% | Stronger: 82.1% |
| Forward P/E | Stronger: 13.8× | 15.6× |
| Dividend yield | 2.63% | Stronger: 5.40% |
| Analysts | Stronger: Buy · 19 | Hold · 12 |
| From its 200-day average | Stronger: +12.2% | +7.2% |
Share price since November 2025
- Keurig Dr Pepper+30.7%
- Kenvue+19.0%
18 Nov 202530 Oct 2026
Keurig Dr Pepper or Kenvue: which is stronger?
- KVUE
Which is more profitable?
Kenvue keeps more of each sale as profit: 10.9% against 7.1%.
- KDP
Which is growing its sales faster?
Keurig Dr Pepper is growing its sales faster: +70.55% over the past year, against +3.24%.
- KVUE
Which has borrowed less?
Kenvue has borrowed less: its debt is 82.1% of what its shareholders own, against 95.0% for Keurig Dr Pepper.
- KDP
Which costs less for the profit it is expected to make?
Keurig Dr Pepper costs less for the profit it is expected to make: 13.8× its forward earnings, against 15.6×.
- KVUE
Which pays more in dividends?
Kenvue pays more back in dividends for what a share costs: 5.40% a year, against 2.63%.
- KDP
Which do analysts rate higher?
Analysts are warmer on Keurig Dr Pepper: Buy, against Hold for Kenvue.
- KDP
Which is in the stronger price trend?
Keurig Dr Pepper's price is in the stronger trend: 12.2% above its 200-day average, against 7.2% above.
What each company does
KDPKeurig Dr Pepper
Keurig Dr Pepper Inc. owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally.
Reports results on 23 February 2027
KVUEKenvue
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America.
Reports results on 4 February 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.